Skip to content

Clinical trials

Completed Observational Fallopian Tube Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Observational Status: Completed Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20062
20081
20092
20103
20115
20121
20141
20153
20164
20172
20183
20194
20203
20212
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Gynecologic Oncology Group4
Memorial Sloan Kettering Cancer Center4
Royal Marsden NHS Foundation Trust4
M.D. Anderson Cancer Center3
Duke University2
Grupo Español de Investigación en Cáncer de Ovario2
University of Southern Denmark2
ARCAGY/ GINECO GROUP1
Abramson Cancer Center at Penn Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms42
Ovarian Neoplasms34
Uterine Cervical Neoplasms9
Endometrial Neoplasms8
Vulvar Neoplasms8
Carcinoma, Ovarian Epithelial7
Vaginal Neoplasms7
Sarcoma5
Stomach Neoplasms5
Uterine Neoplasms5

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.